Latest Articles

Publication Date
All News Scientific
Atezolizumab Combo Displays Noninferior Survival in Endometrial Cancer - CancerNetwork

Atezolizumab Combo Displays Noninferior Survival in Endometrial Cancer CancerNetwork

Published: Oct. 19, 2025, 4:40 p.m.
Read Full Article
Atezolizumab Combo Displays Noninferior Survival in Endometrial Cancer - cancernetwork.com

Atezolizumab Combo Displays Noninferior Survival in Endometrial Cancer cancernetwork.com

Published: Oct. 19, 2025, 4:40 p.m.
Read Full Article
Ibuprofen: How an everyday drug might offer protection against cancer - Medical Xpress

Ibuprofen: How an everyday drug might offer protection against cancer Medical Xpress

Published: Oct. 19, 2025, 4:30 p.m.
Read Full Article
Dominique Dagenais Cedars Run for ovarian cancer marks a decade and honours its late founder in Montreal - CityNews Montreal

Dominique Dagenais Cedars Run for ovarian cancer marks a decade and honours its late founder in Montreal CityNews Montreal

Published: Oct. 19, 2025, 3:21 p.m.
Read Full Article
Exclusive: Sid Mukherjee’s Faeth nets $25M for endometrial cancer study - Endpoints News

Exclusive: Sid Mukherjee’s Faeth nets $25M for endometrial cancer study Endpoints News

Published: Oct. 19, 2025, 9:01 a.m.
Read Full Article
Giorgio Bogani: New Insights into POLE-Mutated Endometrial Cancer with Nodal Involvement - Oncodaily

Giorgio Bogani: New Insights into POLE-Mutated Endometrial Cancer with Nodal Involvement Oncodaily

Published: Oct. 18, 2025, 10:08 p.m.
Read Full Article
Victoria’s Secret Spotlight: Dylan Sprouse and Barbara Palvin Champion Women’s Health and Precancer Diseases Awareness - Oncodaily

Victoria’s Secret Spotlight: Dylan Sprouse and Barbara Palvin Champion Women’s Health and Precancer Diseases Awareness Oncodaily

Published: Oct. 18, 2025, 9:25 p.m.
Read Full Article
The cancer that won’t stop rising - ThePost.co.nz

The cancer that won’t stop rising ThePost.co.nz

Published: Oct. 18, 2025, 4 p.m.
Read Full Article
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - Lelezard

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer Lelezard

Published: Oct. 18, 2025, 12:47 p.m.
Read Full Article
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer - The AI Journal

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer The AI Journal

Published: Oct. 18, 2025, 10:20 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!